Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Augmentin ES-600 for Pediatric Acute Otitis Media
NCT04600752Phase 4Completed
- Sponsor
- GSK
- Start
- May 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin + clavulanate in acute otitis media (AOM), sponsored by GSK. Started May 2022; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT04600752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04600752.